BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 32292506)

  • 21. Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.
    Jain K; Jin CY; Clarke SG
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10101-10106. PubMed ID: 28874563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
    Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
    Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
    Chatterjee B; Ghosh K; Kanade SR
    Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.
    Tsutsui T; Fukasawa R; Shinmyouzu K; Nakagawa R; Tobe K; Tanaka A; Ohkuma Y
    J Biol Chem; 2013 Jul; 288(29):20955-20965. PubMed ID: 23749998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
    Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
    Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions.
    Chakrapani B; Khan MIK; Kadumuri RV; Gupta S; Verma M; Awasthi S; Govindaraju G; Mahesh A; Rajavelu A; Chavali S; Dhayalan A
    Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
    Wang L; Pal S; Sif S
    Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
    Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
    Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
    Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
    J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
    Jiang Y; Yuan Y; Chen M; Li S; Bai J; Zhang Y; Sun Y; Wang G; Xu H; Wang Z; Zheng Y; Nie H
    Theranostics; 2021; 11(18):9162-9176. PubMed ID: 34522232
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-synuclein promotes PRMT5-mediated H4R3me2s histone methylation by interacting with the BAF complex.
    Nakamura T; Sugeno N; Hasegawa T; Ikeda K; Yoshida S; Ishiyama S; Sato K; Takeda A; Aoki M
    FEBS J; 2024 May; 291(9):1892-1908. PubMed ID: 38105619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
    Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
    Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
    Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.
    Köenig A; Linhart T; Schlengemann K; Reutlinger K; Wegele J; Adler G; Singh G; Hofmann L; Kunsch S; Büch T; Schäfer E; Gress TM; Fernandez-Zapico ME; Ellenrieder V
    Gastroenterology; 2010 Mar; 138(3):1189-99.e1-2. PubMed ID: 19900447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine methylation regulates c-Myc-dependent transcription by altering promoter recruitment of the acetyltransferase p300.
    Tikhanovich I; Zhao J; Bridges B; Kumer S; Roberts B; Weinman SA
    J Biol Chem; 2017 Aug; 292(32):13333-13344. PubMed ID: 28652407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.